Clinical trial
Deferment of Imaging for Pulmonary Embolism
NCT00381511 · Azienda Ospedaliera Universitaria Policlinico, Other · Completed
Key facts
| NCT number | NCT00381511 |
|---|---|
| Title | Deferment of Imaging for Pulmonary Embolism |
| Official title | Objective Assessment of Pulmonary Embolism Can be Deferred Without Increased Risk |
| Lead sponsor | Azienda Ospedaliera Universitaria Policlinico, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | low molecular weight heparin |
| Enrollment | 300 |
| Start date | Jan 1, 1999 |
| Completion | Apr 1, 2004 |
| First posted | Sep 28, 2006 |
| Last update posted | Oct 17, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: